FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Corporate Actions Home > Equity > Corporate Information > Corporate Actions

Caplin Point Laboratories LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524742 P/E (TTM) :35.65
ISIN Demat:INE475E01026 Div & Yield %:0.35 EPS (TTM) :47.66
Book Value (RS) :242.5445604 Market Cap (Rs Cr.):12913.25 Face Value (RS) :2
    Change Company 
Dividend
Announcement Date Ex Dividend Date Dividend (%)
31-Dec-2025 02-Jan-2026 0
07-Aug-2025 12-Sep-2025 150
15-May-2025 30-May-2025 150
07-Aug-2024 23-Sep-2024 0
07-Aug-2024 23-Sep-2024 125
Bonus
Record Date Ex Record Date Ratio
No Data Found for Bonus.
Rights
Record Date Ex Record Date Premium Ratio
No Data Found for Rights.
Splits
Record Date Ex Splits Date FV Before FV After
No Data Found for Splits.

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)